LMT PrSM Test Success: Good for Munitions Ramp, But Cash Conversion Still the Hurdle

What happened

Lockheed Martin cleared a key propulsion test for the PrSM Increment 4 missile, targeting a 620-mile range, and is placing $300M in manufacturing bets to accelerate production. This technical milestone supports the bull-case narrative of expanding munitions capacity (PAC-3, THAAD, JASSM, PrSM) that underpins the 20% probability bull scenario in our master report. However, the news does not address the core investment thesis: near-term returns depend on cash conversion, not headlines. The stock still trades at 24.8x P/E with negative free cash flow of $291M in Q1 2026, and the 50% probability base case hinges on working-capital normalization in H2 2026, not incremental test successes. The test is a positive operational signal but does not change the need for two consecutive quarters of positive free cash flow to reduce risk.

Implication

Over the next 6-12 months, the PrSM program could contribute to MFC revenue growth, already up 8% YoY in Q1 2026, but the investment thesis requires proof that backlog converts into cash. Until we see a rebound in free cash flow and no new material reach-forward losses, the stock's risk/reward is unattractive at $516. A sustained move above $580 (trim threshold) would be premature without cash delivery.

Thesis delta

The incremental news flow from PrSM testing reinforces the bull-case production ramp, but does nothing to resolve the central tension in our thesis: weak cash conversion and program charge risk. The base case stays at $540, with a 3-6 month re-assessment window hinging on Q2 and Q3 free cash flow data. No shift in rating, conviction, or price targets.